Skip to main content

Table 3 Comparison between study groups as regards organisms revealed from cultures before treatment

From: A comparative study between effect of combined intravenous and nebulized amikacin versus intravenous amikacin alone in mechanically ventilated patients with ventilator-associated pneumonia (VAP)

  Group A Group B A/B
Klebsiella 11 (35.0%) 6 (20.0%) 0.288
Acinetobacter 3 (10.0%) 11(35.0%) 0.058
Pseudomonas 19 (60.0%) 11(35.0%) 0.113
Citrobacter 0 (0.0%) 1 (5.0%) 0.311
Staphylocci 0 (0.0%) 2 (10.0%) 0.147
Provedinetia 1 (5.0%) 1 (5.0%) 1.000
Proteus 1 (5.0%) 1 (5.0%) 1.000
Enterobacter 1 (5.0%) 0 (0.0%) 0.311
  1. Data are presented as number of cases and percentage of each to total number of cases in each group. p value > 0.05 NS
  2. x2 chi-square test